HeLa (cervical cancer) and MCF7 (breast cancer) cells also displayed enhanced expression of both DR4 and DR5 in response to BFA, whereas HCT116 and MDA-MB231 (breast cancer) cells only showed significant upregulation of DR5 mRNA. This evidence concerns the gene TNFRSF10B and breast carcinoma.